Your browser doesn't support javascript.
loading
Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening - an Evidence-Based Review.
Rath, Werner; Kummer, Julia; Königbauer, Josefine T; Hellmeyer, Lars; Stelzl, Patrick.
Affiliation
  • Rath W; Medizinische Fakultät, Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Kummer J; Klinik für Geburtsmedizin und Klinik für Gynäkologie, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
  • Königbauer JT; Klinik für Geburtsmedizin, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin, Germany.
  • Hellmeyer L; Klinik für Geburtsmedizin und Klinik für Gynäkologie, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
  • Stelzl P; Universitätsklinik für Gynäkologie, Geburtshilfe und Gynäkologische Endokrinologie, Kepler Universitätsklinikum, Johannes Kepler Universität Linz, Linz, Austria.
Geburtshilfe Frauenheilkd ; 83(12): 1491-1499, 2023 Dec.
Article in En | MEDLINE | ID: mdl-38046527
ABSTRACT
Mechanical methods have gained growing interest for pre-induction cervical ripening in women with an unripe cervix, since they have a better safety profile compared to prostaglandins. Balloon catheters have been the gold standard method for decades, while there was a lack of data on synthetic osmotic cervical dilators. Not until 2015, when Dilapan-S was approved by the Food and Drug Administration (FDA) for induction of labor, numerous studies have been published on the use of Dilapan-S in this field. The rate of vaginal deliveries associated with the use of Dilapan-S ranges from 61.6 to 81.7%, and no serious complications needing further interventions have been reported to this date. Dilapan-S was shown to be as effective as the Foley balloon catheter as well as the 10 mg PGE 2 vaginal insert and orally applied misoprostol (25 µg every 2 hours) in achieving vaginal delivery, but patient's satisfaction during the cervical ripening process was significantly higher compared to the other methods and the rate of uterine hyperstimulation was significantly lower compared to prostaglandins (PGs). Minor complications (e.g. vaginal bleeding) associated with the use of Dilapan-S were < 2%, and maternal infectious morbidity was not higher compared to Foley balloon and vaginal PGE 2 or misoprostol. Due to these beneficial properties Dilapan-S might be an ideal option for outpatient cervical ripening, as shown in a recent randomized clinical trial comparing inpatient to outpatient cervical ripening. Furthermore, according to the manufacturers' product information, Dilapan-S is the only cervical ripening method that is not contraindicated for induction of labor in women with a previous cesarean section. Upcoming guidelines should consider synthetic osmotic cervical dilators as an effective and safe method for cervical ripening/induction of labor acknowledging that more evidence-based data are mandatory, particularly in patients with a previous cesarean section.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Geburtshilfe Frauenheilkd Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Geburtshilfe Frauenheilkd Year: 2023 Document type: Article Affiliation country: